Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1971 3
1974 1
1975 3
1976 4
1977 2
1978 15
1979 13
1980 14
1981 15
1982 13
1983 13
1984 23
1985 15
1986 16
1987 16
1988 20
1989 15
1990 12
1991 17
1992 20
1993 9
1994 36
1995 16
1996 27
1997 18
1998 9
1999 21
2000 17
2001 17
2002 18
2003 28
2004 24
2005 22
2006 23
2007 17
2008 14
2009 19
2010 13
2011 12
2012 13
2013 4
2014 7
2015 12
2016 17
2017 8
2018 8
2019 8
2020 2
2021 2
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

669 results
Results by year
Filters applied: . Clear all
Page 1
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Walker JL, Brady MF, Wenzel L, Fleming GF, Huang HQ, DiSilvestro PA, Fujiwara K, Alberts DS, Zheng W, Tewari KS, Cohn DE, Powell MA, Van Le L, Davidson SA, Gray HJ, Rose PG, Aghajanian C, Myers T, Alvarez Secord A, Rubin SC, Mannel RS. Walker JL, et al. Among authors: alberts ds. J Clin Oncol. 2019 Jun 1;37(16):1380-1390. doi: 10.1200/JCO.18.01568. Epub 2019 Apr 19. J Clin Oncol. 2019. PMID: 31002578 Free PMC article. Clinical Trial.
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.
Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr, Alberts DS. Peters WA 3rd, et al. Among authors: alberts ds. J Clin Oncol. 2000 Apr;18(8):1606-13. doi: 10.1200/JCO.2000.18.8.1606. J Clin Oncol. 2000. PMID: 10764420 Clinical Trial.
Clinical trials in recurrent ovarian cancer.
Friedlander M, Trimble E, Tinker A, Alberts D, Avall-Lundqvist E, Brady M, Harter P, Pignata S, Pujade-Lauraine E, Sehouli J, Vergote I, Beale P, Bekkers R, Calvert P, Copeland L, Glasspool R, Gonzalez-Martin A, Katsaros D, Kim JW, Miller B, Provencher D, Rubinstein L, Atri M, Zeimet A, Bacon M, Kitchener H, Stuart GC; Gynecologic Cancer InterGroup. Friedlander M, et al. Among authors: alberts d. Int J Gynecol Cancer. 2011 May;21(4):771-5. doi: 10.1097/IGC.0b013e31821bb8aa. Int J Gynecol Cancer. 2011. PMID: 21543939 Review.
Salpingectomy as a means to reduce ovarian cancer risk.
Daly MB, Dresher CW, Yates MS, Jeter JM, Karlan BY, Alberts DS, Lu KH. Daly MB, et al. Among authors: alberts ds. Cancer Prev Res (Phila). 2015 May;8(5):342-8. doi: 10.1158/1940-6207.CAPR-14-0293. Epub 2015 Jan 13. Cancer Prev Res (Phila). 2015. PMID: 25586903 Free PMC article. Review.
Strategies for skin cancer prevention.
Harris RB, Alberts DS. Harris RB, et al. Among authors: alberts ds. Int J Dermatol. 2004 Apr;43(4):243-51. doi: 10.1111/j.1365-4632.2004.01966.x. Int J Dermatol. 2004. PMID: 15090005 Review. No abstract available.
Chemoprevention of human skin cancer.
Einspahr JG, Stratton SP, Bowden GT, Alberts DS. Einspahr JG, et al. Among authors: alberts ds. Crit Rev Oncol Hematol. 2002 Mar;41(3):269-85. doi: 10.1016/s1040-8428(01)00185-8. Crit Rev Oncol Hematol. 2002. PMID: 11880204 Review.
Cancer Prevention: Obstacles, Challenges and the Road Ahead.
Meyskens FL Jr, Mukhtar H, Rock CL, Cuzick J, Kensler TW, Yang CS, Ramsey SD, Lippman SM, Alberts DS. Meyskens FL Jr, et al. Among authors: alberts ds. J Natl Cancer Inst. 2015 Nov 7;108(2):djv309. doi: 10.1093/jnci/djv309. Print 2016 Feb. J Natl Cancer Inst. 2015. PMID: 26547931 Free PMC article. Review.
Selenium and cancer: risk or protection?
Clark LC, Alberts DS. Clark LC, et al. Among authors: alberts ds. J Natl Cancer Inst. 1995 Apr 5;87(7):473-5. doi: 10.1093/jnci/87.7.473. J Natl Cancer Inst. 1995. PMID: 7707429 No abstract available.
Novel antitumor 2-cyanoaziridine-1-carboxamides.
Iyengar BS, Dorr RT, Alberts DS, Hersh EM, Salmon SE, Remers WA. Iyengar BS, et al. Among authors: alberts ds. J Med Chem. 1999 Feb 11;42(3):510-4. doi: 10.1021/jm980600x. J Med Chem. 1999. PMID: 9986721
669 results